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Abstract
Background: A central nervous system (CNS) disease outbreak caused by small ruminant lentiviruses (SRLV) has
triggered interest in Spain due to the rapid onset of clinical signs and relevant production losses. In a previous
study on this outbreak, the role of LTR in tropism was unclear and env encoded sequences, likely involved in
tropism, were not investigated. This study aimed to analyze heterogeneity of SRLV Env regions - TM amino
terminal and SU V4, C4 and V5 segments - in order to assess virus compartmentalization in CNS.
Results: Eight Visna (neurologically) affected sheep of the outbreak were used. Of the 350 clones obtained after
PCR amplification, 142 corresponded to CNS samples (spinal cord and choroid plexus) and the remaining to
mammary gland, blood cells, bronchoalveolar lavage cells and/or lung. The diversity of the env sequences from
CNS was 11.1-16.1% between animals and 0.35-11.6% within each animal, except in one animal presenting two
sequence types (30% diversity) in the CNS (one grouping with those of the outbreak), indicative of CNS virus
sequence heterogeneity. Outbreak sequences were of genotype A, clustering per animal and compartmentalizing
in the animal tissues. No CNS specific signature patterns were found.
Conclusions: Bayesian approach inferences suggested that proviruses from broncoalveolar lavage cells and
peripheral blood mononuclear cells represented the common ancestors (infecting viruses) in the animal and that
neuroinvasion in the outbreak involved microevolution after initial infection with an A-type strain. This study
demonstrates virus compartmentalization in the CNS and other body tissues in sheep presenting the neurological
form of SRLV infection.
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Background
Small ruminant lentiviruses (SRLVs) cause arthritis,
mastitis, interstitial pneumonia (Maedi) and leukoence-
phalitis (Visna) in sheep and goats [1]. The clinical form
Visna in sheep was first described in Iceland during the
Visna Maedi Virus (VMV) epidemic in the first half of
the last century [2]. From then, this neurologic form has
been reported only sporadically [3-5]. However, in the
last few years, the neurological form of SRLV disease
has been diagnosed in numerous sheep of North-Wes-
tern Spain, causing production losses [6]. In this out-
break, clinical signs usually appear at 1-2 years of age,
but have been detected in animals as young as 4 months
[7]. However, in other geographic areas of the world,
Visna appears in animals over 2 years of age [2,8]. Also,
in the animals affected by Visna within the outbreak,
lesions frequently involve the white matter of the spinal
cord [9,10] whereas in reported experimental Visna
cases, lesions usually appear mainly in the periventricu-
lar areas of the brain [5].
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the early phases of sheep SRLV infection, as it occurs
in human CNS with human immunodeficiency virus
infections (HIV; [11]). In HIV infections, viral quasis-
pecies change in their adaptation to certain cell types,
d u et od i f f e r e n c e si ns e l e c t i v ep r e s s u r et h a tm a yb e
exerted, for example, by the immune system [12]. Con-
sequently, the flow of genes among viral subpopula-
tions is significantly restricted, leading to genetically
distinct subpopulations and development of compart-
mentalization [13-15]. Hence, the genetic heterogeneity
between subpopulations of the individual could be
explained by both an independent microevolution and
the presence of related but phylogenetically distinct
infecting virus genotypes [15,16]. Viral populations dis-
tributed in compartments may have different phenoty-
pic characteristics, such as cell tropism [17], drug
resistance [18-21] and pathogenicity [22]. Further stu-
dies on viral diversification, compartmentalization and
adaptation of the virus to the brain are needed [13].
The CNS provides a unique environment for the repli-
cation of lentiviruses. The blood-brain barrier presents
specialized capillary endothelial cells, linked to each
other by highly selective narrow bridges that may
restrict viral traffic. During viral infection, a single
strain appears to be able to cross the blood-brain bar-
rier and establish the infection in the brain, which is
otherwise isolated from the peripheral blood and the
immune response [14,23]. Viral genome structure may
also contain key features determining the fate of
infection.
In SRLV infection, evidence of the relationship
between SRLV-derived clinical manifestation and strain
genetic features has been described [24], but there is no
consensus on the specific viral genetic region that deter-
mines cell or tissue tropism [25]. Tissue tropism may be
dependent on the virus promoter sequence of both
VMV and HIV [26,27]. However, sequence divergence
found in viral promoter does not ensure changes in
transcriptional activities and/or biological characteristics.
LTR alone does not exert this function and other viral
genes could be involved [25].
Different HIV and feline immunodeficiency virus (FIV)
studies, based on a hypervariable region of the viral sur-
face protein (SU), have revealed tissue compartmentali-
zation of the virus [14]. In HIV and FIV Env, the V3
region is a determinant of cell tropism and replication
efficiency, since it is thought to be related to the adsorp-
tion and fusion of the virus to the cell [23,28-30].
Furthermore, in chronically infected individuals, particu-
lar amino acids of the V3 region modulate neurotropism
and neurovirulence [14]. In SRLV, five variable (V1 to
V5) and four conserved (C1 to C4) regions have been
identified in the SU protein [31] and the function of V4
hypervariable region has been found analogous to that
of the V3 region of HIV [32,33].
In this work involving Env SU regions (V4, C4 and
V5), and the amino terminal sequence of the Env TM
protein, we first determined the existence of viral
sequence diversity in the CNS cells [choroid plexus cells
(CPx), spinal cord cells (SC)], broncho-alveolar lavage
macrophages (BAL), lung tissue (L), mammary gland tis-
sue (MG), and peripheral blood mononuclear cells
(PBMC) and analyzed the phylogenetic relationships of
SRLV within animals belonging to an outbreak of clini-
cal Visna [9]. Phylogeography approaches were also
applied to identify the common ancestor sequences of
the viral quasispecies. Finally, the existence of compart-
mentalization and/or presumptive positive selection of
viral genomes was assessed, with special emphasis on
CNS comparisons in order to better understand genetic
diversity involved neurotropism and neurovirulence.
Results
Clinical signs and lesions
The animals included in this study presented symptoms
compatible with the nervous form of VMV, such as
hindleg ataxia or even paralysis, sternal or lateral recum-
bency and pedaling. Histopathological examination indi-
cated the presence of severe lesions in the CNS in all
the animals. In three of these animals the CNS lesions
were located only in the SC, which were characterized
by non-suppurative perivascular cuffs and demyelina-
tion, when affecting the neuroparenchyma. Seven of the
animals showed also mild interstitial pneumonia,
denoted by lymphoid infiltration in the lung alveolar
walls. Only two of the animals had lesions in the MG,
characteristic of a mild non-purulent interstitial mastitis
(Table 1). No other pathogens were identified in the
brain or other organs in the animals under study.
ELISA and PCR
All the animals had anti-SRLV antibodies as assessed by
Elitest [34], with OD ratios ranging from 3 to 18 (Table 1).
In spite of the availability of PBMC, BAL, MG (except for
the male), L, CPx and SC samples from all the animals for
PCR testing, only some samples allowed proviral amplifi-
cation (Table 1). PCR amplification detected proviral LTR
DNA mostly in tissues of the CNS (SC and CPx), whereas
samples from L or MG yielded few positives and inconsis-
tent results, respectively. LTR SRLV sequences obtained in
this study had a classical genotype A organization and
characteristics.
The env PCR amplification was successful in all the
animals, SC being always amplified (data not shown).
BAL and CPx yielded PCR positive results in 4 of the 8
animals. The number of clones was also variable among
samples and animals.
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A representative sample of the env amplicons was
sequenced and genotyped, revealing that, like in LTR,
env SRLV sequences obtained in this study had a classi-
cal genotype A characteristics, closer to VMV than to
caprine arthritis encephalitis virus (CAEV) prototypes
(not shown). Within each animal, the mean diversity of
env sequences from CNS ranged from 0.35 to 11.6%
(Table 2). The analysis of nucleotide diversity showed a
quite uniform distribution of distances, except for the
animal No. 333 having two distant sequence sub-sets
(333a and 333b) in different tissues, including CNS. One
of them grouped with those of the outbreak but not the
other (30% diversity between both sequence sub-sets).
Diversity observed among sequences from the CNS in
different animals ranged between 11.1 and 16.1%.
Phylogenetic analysis of SRLV sequences within animals
is shown in Figure 1 and globally in Additional file 1: ‘Phy-
logenetic tree including 350 partial env sequences from 8
animals’. With the exception of animal 333, sequences
belonging to the same animal clearly clustered together. In
addition, within the animal, sequences showed a strong tis-
sue compartmentalization, confirming the presence of dif-
ferent viral sub-populations in a single host. This was
compatible with either a clonal evolution after initial infec-
tion with a single strain or a polyclonal origin of infecting
viral strains. Sequence distribution in tissues differed
between animals. In addition, MG and L sequences fre-
quently formed clearly defined clades, while PBMC
sequences were the most variable and were usually located
in different clades within an animal (Figure 1). Individual
phylogram study revealed the existence of sequences in
CNS, L, and/or MG that could derive from BAL and/or
PBMC. In animals 166 and 368, sequences from CNS (Cpx
and SC) clustered close to each other. In both animals,
these sequences, when present, were also close to BAL, like
SC sequences from animal 336. In fact, in sheep 166, both
CNS and BAL sequences belonging to the late clade
appeared to descend from BAL, L and/or PBMC (early
clade). In sheep 333, there were differences in sequence
distribution between the two sequence sub-sets. In one of
them BAL and PBMC sequences were close to those from
Table 2 Nucleotide and amino acid diversity, ω statistic and ancestor tissue. Nucleotide diversity, amino acid diversity,
ω statistic (ratio between average number of non-synonymous substitutions per non-synonymous site, dN; and
average number of synonymous substitutions per synonymous site, dS), and ancestor tissue for SRLV clones obtained
from eight sheep of the Visna outbreak
Sheep No. No. of clones Nucleotide diversity Amino acid diversity dN/dS (ω) Ancestor tissue
a
Mean Standard Error Mean Standard Error
166 90 0.0542 0.0029 0.0312 0.0017 0.690547 BAL
223 32 0.0372 0.0036 0.0333 0.0039 0.982374 PBMC
292 7 0.0035 0.0007 0.0031 0.0013 0.459471 na
b
333 74 0.1158 0.0104 0.0496 0.0042 0.283522 PBMC
336 64 0.0659 0.0045 0.0342 0.0026 0.442547 BAL
368 43 0.0372 0.0033 0.0312 0.0024 0.722284 BAL
697 12 0.0188 0.0043 0.0179 0.0034 0.692030 na
698 28 0.0178 0.0042 0.0273 0.0041 0.346625
c na
a Inferences on tissue origin of most recent common ancestor were conducted only on large dataset (n > 30)
b na: non applicable
c dN/dS value (ω) was calculated excluding sequences with stop codons
Table 1 Diagnosis and lesions. Results on PCR (LTR region), ELISA (Elitest) and histopathology obtained from eight
sheep with Visna clinical symptoms belonging to the Castilla-y-León outbreak
Animal No. Age (years) Sex Breed LTR-PCR Elitest ratio Lesions
PBMC SC CPx MG L Brain SC CPx MG L
166 2-3 M Assaf + + + NT + 13.87 - +++ - NT +
223 > 2 F Assaf + NT + +/- - 18.56 +++ +++ NT - +
292 2 F Assaf - + - + + 11.06 - +++ - - ++
333 > 4 F Assaf NT + + +/- - 3.81 +++ - + - +
336 3 F Assaf NT + - +/- - 3.37 + +++ + - ++
368 5 F Milchschaf - + + + - 5.87 +++ +++ ++ - -
697 3 F Assaf - - NT - - 3.12 - +++ - ++ +
698 2 F Assaf + + - + - 14.56 +++ +++ + + +
PBMC, peripheral blood mononuclear cells; SC, spinal cord; CPx, choroid plexus; MG, mammary gland; L, lung; NT, not tested
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proximity of PBMC sequences to CNS (CPx), MG and L.
In animal 223 CPx sequences belonged to a cluster differ-
ent from that of SC sequences of the CNS, confirming the
existence of different viral sequence clusters within the
CNS, and PBMC sequences were close to the tree root.
Also, sequences from a particular tissue appeared to have
evolved within the tissue; this was the case of MG
sequences in animals 336 and 698 or, less markedly SC
sequences in animal 697, among others. Thus, once in the
target organ, the virus seemed to have evolved, allowing
the appearance of new clones within the same tissue.
The common ancestor state was then reconstructed,
using Bayesian methods recently developed in
Figure 1 Phylogenetic relationships among sequences belonging to the same animal. Animal identification number is reported for each
subtree. Taxa names include the tissue from which the sequence was obtained and the clone number. Tissues are coded as follow: broncho-
alveolar macrophages, BAL; choroid plexus, CPx; spinal cord, SC; peripheral blood mononuclear cells, PBMC; mammary gland, MG; lung, L.
Posterior probabilities of each node are reported above branches. Sequences from animal 698 with stop codons are reported in grey.
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were estimated under the Bayesian Skyline Plot uncorre-
lated lognormal relaxed clock model. The convergence
of chains was reached (ESS > 200 in all analyses) and
Maximum Clade Credibility trees were obtained for
each animal. The results showed that viral evolution
within animals followed the usual infection paths. Speci-
fically, in animals 166, 336 and 368, where sequences
from BAL were present, bronchoalveolar macrophages
were identified as the most likely tissue infected by the
viral common ancestor. In animals 223 and 333, in
which BAL samples were unavailable, PBMC had the
highest probability to be the tissue infected by the viral
ancestor. These data strongly suggest that the infection
starts from the lungs and later reaches other tissues
through the blood. An interesting aspect of these results
is that CNS, lung and mammary gland are terminal
clades in this evolutionary model, associated to BAL and
PBMC taxa (Table 2).
In this evolutionary context, the average number of
non-synonymous substitutions per non-synonymous site
(dN) and the number of synonymous substitutions per
synonymous site (dS) were determined for proviral
sequences obtained from each animal. The dN rates
were lower than the dS rates in all the animals, indicat-
ing the presence of within-host purifying selection
(against amino acid sequence variability), but in favour
of synonimous substitutions leading to nucleotide het-
erogeneity and compartmentalization (Table 2).
Compartmentalization regarding “segregation” of
sequences between different animals and between tis-
sues of a particular animal was assessed (Tables 3 and
4) according to parsimony score (PS), association index
(AI) and monophyletic clade (MC) values. Results on PS
and AI showed weak phylogeny-trait association and sig-
nificant monophyletic clade (MC) value, altogether indi-
cative of tissue compartmentalization in six of the
studied animals. In particular, CNS sequences belonged
to a different cluster compared to other tissues, within
the animal. This was observed in the six animals that
h a da tl e a s tt w ot i s s u e s( o n eo ft h e mb e i n gC N S )f r o m
which the number of sequences obtained was sufficient
(≥ 28 clones per animal) to carry out the study, demon-
strating and confirming the existence of CNS tissue
compartmentalization. Lack of significance in PS, AI
and MC analyses was observed only rarely, when a low
number of sequences was available (animals 292 and
697; Table 4).
Overall, these results indicate strong sequence segre-
gation between animals and the existence of tissue com-
partmentalization within the animal.
A signature pattern analysis was performed in search
of conserved amino acid motifs specific to a particular
tissue, but we were unable to find this pattern in the
genetic region under analysis. Also analysis of the
potential Asn-X-Ser/Thr glycosylation site was carried
out [36]. This site was present in sequences from all the
animals (except No. 223) and was equally distributed in
different tissues, discarding glycosylation pattern as a
possible explanation for compartmentalization.
Discussion
This study provides evidence of VMV compartmentali-
zation within the CNS and other tissues and confirms
its existence in the mammary gland as previously
described between blood and colostrum [32] amongst
seropositive naturally infected small ruminants. The
sheep had Visna-like severe lesions in the CNS, with
non-suppurative meningo-encephalitis [10]. According
to the specific feature of this outbreak [6,7], most ani-
mals presented lesions in the spinal cord and 50 percent
in the brain. Most of them also presented lung lesions.
VMV sequence distribution differed between animals, as
revealed by phylogenetic analysis. The different com-
partmentalization patterns may be explained by differ-
ences in host genetic susceptibility, anatomical features,
Table 3 SRLV sequences segregation. SRLV sequence compartmentalization (segregation) between the eight Visna-
affected animals, using Bayesian MCMC approach for determination of Association Index (AI), Parsimony Score (PS)
and Monophyletic Clade (MC) values
Statistic No. of sequence Mean value 95% Confidence interval (CI) Significance
AI 350 0.046 1 × 10
-11 -0.250 p < 0.00001
PS 350 7.752 7-8 p < 0.00001
MC (166) 90 48.973 40-68 p < 0.00001
MC (223) 32 31.747 32-32 p < 0.00001
MC (292) 7 6.939 7-7 p < 0.00001
MC (333) 74 70.786 40-74 p < 0.00001
MC (336) 64 63.361 64-64 p < 0.00001
MC (368) 43 34.176 9-43 p < 0.00001
MC (697) 12 11.825 11-12 p < 0.00001
MC (698) 28 27.655 28-28 p < 0.00001
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the animal (n = 7)*, using Bayesian MCMC approach for determination of Association Index (AI), Parsimony Score (PS)
and Monophyletic Clade (MC) values
Animal No. Statistic No. of sequences Mean 95% Confidence interval (CI) Significance
166 AI 90 2.262 1.433-3.125 p < 0.00001
PS 90 24.845 22-27 p < 0.00001
MC (BAL) 27 9.815 5-11 p < 0.01
MC (L) 12 3.260 2-4 p < 0.01
MC (SC) 21 3.541 2-6 p < 0.05
MC (PBMC) 20 3.411 3-5 p < 0.05
MC (CPx) 10 1.773 1-3 p < 0.05
223 AI 32 0.381 0.209-0.602 p < 0.00001
PS 32 7.896 7-9 p < 0.00001
MC (CPx) 13 7.986 8-8 p < 0.01
MC (L) 4 2.925 2-3 p < 0.01
MC (MG) 6 2.035 2-2 p < 0.05
MC (PBMC) 5 4.029 4-4 p < 0.01
MC (SC) 4 1.151 1-2 Non significant
333 AI 74 1.034 0.552-1.547 p < 0.00001
PS 74 15.723 14-17 p < 0.00001
MC (BAL) 14 6.583 3-12 p < 0.01
MC (CPx) 16 3.089 2-5 p < 0.05
MC (L) 8 4.778 3-5 p < 0.01
MC (MG) 6 3.977 4 -4 p < 0.01
MC (PBMC) 17 4.141 3-7 p < 0.01
MC (SC) 13 4.175 4-5 p < 0.01
336 AI 64 0.002 1.160 × 10
-9 - 1.953 × 10
-4 p < 0.00001
PS 64 4.204 4-5 p < 0.00001
MC (BAL) 14 8.348 5-10 p < 0.01
MC (L) 12 11.983 12 -12 p < 0.01
MC (MG) 25 23.300 16-25 p < 0.01
MC (SC) 13 10.967 11 -11 p < 0.01
368 AI 43 0.725 0.333-1.115 p < 0.00001
PS 43 7.961 7-9 p < 0.00001
MC (BAL) 14 3.872 2-7 p < 0.01
MC (CPX) 15 8.632 5-11 p < 0.01
MC (L) 3 1.013 1 -1 Non significant
MC (MG) 1 1.000 1 -1 Non significant
MC (SC) 10 8.655 6-10 p < 0.01
697 AI 15 0.000 0-1.878 × 10
-5 p < 0.00001
PS 15 1.000 1 -1 p < 0.00001
MC (SC) 12 12.000 12 -12 p < 0.01
698 AI 28 0.446 0.014-0.839 p < 0.00001
PS 28 5.514 4-7 p < 0.00001
MC (MG) 16 4.227 2-7 p < 0.05
MC (PBMC) 4 1.416 1-2 Non significant
MC (SC) 8 6.264 6-7 p < 0.01
* The animal 292 was not included because less than 10 sequences were available
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of mutation and replication, generating a quasispecies
[37], and variants which may escape from surveillance
[38]. Compartmentalization may involve genetic drift
and founder effects [23], and/or being a consequence of
different selective pressures [12].
Respiratory secretions containing infected alveolar
macrophages can be responsible for SRLV transmission,
especially in intensive rearing systems such as those
applied in the Assaf breed of the animals under study
[39]. Consequently, blood, lymph, and then target tis-
s u e s ,s u c ha sL ,M G ,C P xa n dS Co fC N S ,b e c o m e
infected [40]. Following purifying selection (as observed
in this study) the virus evolves and compartmentalizes,
producing a quasispecies. Thereafter, the virus may go
back through lymphoid and blood cells to other tissues.
In line with this scheme and using a novel methodology
previously applied to investigate geographical origin of
sequences [35], we found as expected, that intra-host
ancestor sequences were not located in the CNS or
other tissues, but in BAL or PBMC (when available).
PBMC sequences were present in different clades, dis-
playing the broadest variation per tissue, which is com-
patible with migration of virus from blood to tissues
and vice versa.
However, particular ancestor/primary sequences could
not be always identified. This may be due to the una-
vailability of PCR amplification in some samples. Thus,
clones analyzed in the ancestor tissues (BAL and
PBMC) may have not included the complete spectrum
of ancestor viral sequences. Besides, all samples were
obtained at a single time point (necropsy) even though
t h et i m ep o i n t so fi n f e c t i o nb yap a r t i c u l a rv i r u sm a y
have not been simultaneous at different body sites. Also,
there may have been re-infection events from inside or
outside the body (like sheep 333, apparently with two
main infections). Finally, body sites other than BAL
(such as nasal and conjunctival mucosa) may have been
the initial source of infection.
The virus under study belonged to the genotype A,
also involved in other Visna infections [41]. Like in CNS
studies of HIV [42] and in contrast with findings on FIV
[14] infections, we were unable to find any CNS-specific
signature pattern. In these lentiviruses, V3-V5 regions of
SU encoding neutralizing epitopes may mutate, leading
to viral resistance to existing antibodies also affecting
cell tropism [18,30], including neurotropism and neuro-
virulence [14,43]. Amongst the SRLV sequences under
study (TM and V4-V5), V4 - claimed to have a function
analogous to that of HIV-V3 region [32,33] - was the
most variable. Although variable and constant regions
within the SRLV SU protein may trigger the production
of neutralizing antibodies [31], the main sites/epitopes
involved in this process have not been identified.
Additional factors or genetic regions, such as those
encoding viral proteins (Vif) that interact with host
molecules (APOBEC; [44]), might be involved in
neuroinvasion.
Of the 16 MG clones of animal 698, 12 showed a non-
synonymous transition C to T at the same position,
inserting a stop codon along the env region encoding
the SU protein (Figure 1). The finding of stop codons
along with codifying sequences suggests the emergence
of quasispecies, the presence of a high rate of viral evo-
lution and thus the existence of defective interfering
particles/heteroclites. However, numerically realistic
model studies suggest that these particles are unlikely to
survive or influence viral dynamics [45].
Work on HIV and simian immunodeficiency virus
( S I V )h a ss h o w nt h a tv i r a le v o l u t i o ni nt h eb r a i ni s
peculiar in that this immunologically privileged site
allows a low level of viral replication [13] before disease
onset [46], but it may be considered a “sanctuary” where
the virus can evolve freely, avoiding the effects of adap-
tive immunity and/or therapy [12]. In line with this, the
least conserved Env amino acid sequence was found in
SC and the most conserved in L (data not shown). The
diagnostic LTR-PCR used in this study only yielded con-
sistent amplifications when using CNS as DNA source,
since all animals were seropositive and yielded PCR-spe-
cific amplicons in CNS (Table 1). This strongly suggests
that CNS is a preferred site of infection in the Visna
affected animals involved. SRLV replication occurred in
brain, since viral antigens p25 and gp130 were detected
in CNS by immunohistochemistry and two fully replica-
tive viral isolates, able to replicate in SCP cells, were
obtained from SC and cerebrospinal fluid from two of
the diseased sheep used (Nos. 697 and 698, respectively)
[47]. This is compatible with studies on HIV infections,
where viral replication in the CNS occurs in diseased
individuals, leading then to divergent trends in different
compartments [28].
This study shows that different SRLVs can coexist in
the CNS from a Visna diseased sheep. This was clearly
observed in animal 333, infected by two viruses (333a
and 333b sequences), one closer to the remaining out-
break sequences than the other. Under the hypothesis
that the strain’s genetic makeup (in the SU genetic
regions analyzed) and induced pathology are associated,
the set of sequences most similar to other sequences in
the outbreak would be causing the nervous clinical
signs. The CNS 333a sub-set sequences were essentially
from CPx (n = 7) and to a lower extent from SC (n =
2), whereas 333b ones were similarly represented in CPx
(n = 9) and SC (n = 11). This would be consistent with
a recent infection in the case of 333a, in which the virus
from infected CPx cells (blood-CSF barrier) reached
only a few SC sites. In the case of 333b sequences, the
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extended to various SC sites after CPx initial infection.
Whether different viruses infected different cells of the
same tissue (such as choroid plexus) or different viruses
coinfected the same cell type remains unknown. In any
case, this study demonstrates in VMV infections that,
like in those by SIV, the physical continuity of the brain
tissue does not necessarily result in phylogenetic proxi-
mity [13]. Disruption of the blood-brain or the blood-
CSF (CPx) barriers may have taken place, as proposed
in FIV and HIV infections [43,48]. In HIV infections,
CPx may allow a bidirectional productive lentiviral
infection of CNS and peripheral organs, having often a
mixture of viral sequences [43,46]. Similarly in this
study, VMV-infected cells may have crossed the CPx
barrier to colonize CSF and SC, and gone back from
there to blood through blood-brain or blood-CSF (CPx)
barriers.
Conclusions
The results obtained in this work provide evidence of
type A SRLV compartmentalization in the CNS and
other tissues. These viruses can be found in tissues that
allow horizontal transmission among the animals of the
outbreak. Ancestor tissue estimation strongly suggests
that infection appears to start in alveolar macrophages
(BAL) or blood (PBMC) when BAL was unavailable.
Likely, PBMC became infected after intake of virus or
infected cells/particles through respiratory and/or mam-
mary secretions, including colostrum/milk. Moreover,
the identification of sequences from mammary gland
(MG) as terminal tips in the trees supports this hypoth-
esis, indicating the two main compartments from which
the virus can be transmitted.
Through this route, circulating A viruses cause neuro-
pathological disease in the Assaf animals under study. Sub-
sequently and according to phylogeny observations, viruses
may either reach different tissues including the CNS, lung,
and mammary gland and compartmentalize or be trans-
mitted from ancestor tissues (BAL/PBMC) to new hosts.
Methods
Animals and diagnostic tests
This study involved seven sheep of the Assaf breed - six
females (223, 292, 333, 336, 697 and 698) and one male
(166) - and a Milchschaf breed ewe (368), ranging in
age from 2 to 5 years. Sheep were from different dairy
farms (except for 333 and 336, which were from the
same flock) located in the Autonomous Community of
Castilla-y-León (North-Western Spain), where several
cases of Visna Maedi nervous form had been previously
reported [9]. All sheep showed clinical nervous symp-
toms and post-mortem analysis was consistent with
Visna lesions (Table 1).
Animal handling, euthanasia and experimental proce-
dures were carried out in compliance with the current
European and national (RD 1201/2005) regulations, with
the approval of the Comité de Ética y Experimentación
Animal of the University of León and authorization of
the Gobierno de Castilla y León. Euthanasia was done
by intravenous injection of barbiturate overdose fol-
lowed by exsanguination. Complete necropsy analysis
was performed in the animals. Animals were submitted
to necropsy and used for clinical and pathology studies
a tt h eU n i v e r s i t yo fL e ó nf o l l o w i n gt h ef a r m e r s ’ request
and consent.
For serological and molecular diagnosis of SRLV infec-
tion, animals were analyzed serologically using a com-
mercially available ELISA (Elitest-MVV
®;H Y P H E N
Biomed, France); and by PCR on viral promoter LTR
(about 300 bp), using primers and a procedure pre-
viously described [49] for proviral DNA amplification.
Samples
Whole blood from each animal was collected to isolate
plasma for ELISA and peripheral blood mononuclear
cells (PBMC) for PCR analysis. These were isolated
from EDTA-blood samples by Ficoll-Hypaque gradient
centrifugation (d = 1.077; Lymphoprep Axis-Shield,
Oslo). One cubic centimetre samples of spinal cord
(SC), choroid plexus (CPx), mammary gland (MG), lung
(L), and bronchoalveolar lavage (BAL) were also col-
lected post-mortem and embedded in RNAlater (Qia-
gen) until use. Samples from brain, SC, L and MG were
also obtained and fixed in buffered formalin 10% for his-
topathological studies. Genomic DNA was extracted
from PBMC, BAL and tissue samples with QIAamp
®
DNA Blood Mini Kit (Qiagen), following the manufac-
turer’s instructions. Tissue samples were previously
lysed in buffer (100 mM Tris-HCl pH 8.5; 5 mM EDTA;
400 mM NaCl; 0.2% SDS) containing Proteinase K (50
μg/ml per 10
7 PBMC, Sigma) at 56°C for 1 h.
PCRs and cloning for compartmentalization
To avoid template resampling [50], DNA was diluted in
fivefold series and amplified by PCR in triplicate (limit-
ing-dilution PCRs). Diluted DNA was used in a semi-
nested PCR that was carried out with primers previously
described [51] slightly modified for this study. Briefly,
the reaction mix of the first round of seminested PCR
consisted in: Buffer Certamp 1 × (Biotools), 2 mM
MgCl2 (Biotools), 225 μM of each dNTP (Biotools), 600
nM of each primer, 0.04 U/μl of Certamp enzyme (Bio-
tools) and sample DNA diluted 5-fold serially in a final
volume of 50 μl. PCR conditions were: initial denatura-
tion step for 5 min at 95°C followed by 45 cycles of 95°
C for 60 s, annealing at 47°C for 60 s and extension at
72°C for 60 s, followed by a final extension step of 10
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GARCAYATGACA-3’ (7272-7292 nt); #564 RV 5’-
GCYAYRTGCTGYACCATGGCATA-3’ (8089-8067 nt).
For the second round, 5 μl of the first PCR were trans-
ferred to the new reaction mix. Reaction conditions for
the second round of PCR were identical to those
described for the first round, with the exception that the
#567 FW primer (#567 FW 5’-GGGNACNARIA-
CRAAYTGGAC-3’; 7481-7501 nt) was used and the
annealing temperature was increased to 49°C. A 607 bp
amplicon was obtained encompassing the C-terminal
part of surface protein (SU) including V4, C4 and V5
regions and the N-terminal part of transmembrane
(TM) protein encoded by the env gene (7481-8089 nt of
CAEV CO, M33677). Amplified products were chilled at
4°C. A negative control reaction without template DNA
was included for each primer pair to control potential
contaminations. In order to minimize the risk of con-
tamination, mixing of reagents, sample preparation, and
analysis of the amplified products were performed in
three separate areas.
PCR amplicons were resolved on 1.5% agarose gels,
and bands of the expected sizes were excised and puri-
fied with QIAquick Gel Extraction Kit (Qiagen), and
subsequently cloned into the vector pGEMT-easy
® (Pro-
mega) following the manufacturer’s instructions. Fifty to
100 transformed colonies (Escherichia coli XL1-Blue)
were picked per sample and grown overnight at 37°C in
LB medium (1% Bacto Tryptone, 0.5% yeast extract, 1%
NaCl) with 100 μg/ml ampicillin. After selection of posi-
tive clones upon screening by restriction enzyme diges-
tion (EcoRI), plasmid DNA was purified from bacterial
culture using the Quantum Prep
® Plasmid Miniprep kit
(Bio-Rad) according to the manufacturer’s instructions.
Purified plasmid DNA was sequenced using an ABI
PRISM 310 Genetic Analyzer (Applied Biosystems).
Sequence analysis
The total number of sequences obtained in the group of
8 animals was 350: 54 from CPx, 88 from SC, 39 from
L, 46 from PBMC, 69 from BAL and 54 from MG.
Nucleotide sequences were analyzed with Chromas
2.23 (Technelysium, Helensvale, Australia) and edited
using BioEdit software [52]. The corresponding amino
acid sequences were obtained according to the Expasy
server. Multiple alignments for comparison and phyloge-
netic studies were made with the ClustalW [53] respect-
ing the reading frame. The nucleotide distance matrix
was calculated with the PAUP* software [54]. The pre-
sence of natural selection was evaluated as the estima-
tion of ω,t h er a t i ob e t w e e nt h en u m b e ro fn o n -
synonymous substitutions per non-synonymous site
(dN) and the number of synonymous substitutions per
synonymous site (dS). The ω estimation was carried out
using Single-Likelihood Ancestor Counting (SLAC, [55])
method implemented in Datamonkey webserver [56].
A phylogenetic tree was created evaluating the best
model of molecular evolution (ModelTest software; [57])
and using Bayesian heuristic approaches (BEAST (16)
and MrBayes software; [58]).
To explore the overall compartmentalization in the
sequence data we employed a Bayesian Markov chain
Monte Carlo (MCMC) approach (program BaTS; [59]).
This analysis was based on the trees output from the
MrBayes BEAST analysis described above, with 10%
removed as burn-in and employing 1000 replications.
From these trees we computed the significance of the
parsimony score (PS) and association index (AI) statis-
tics of the strength of geographical clustering by phylo-
geny [59]. In addition, we computed the monophyletic
clade (MC) statistic that measures the strength of clus-
tering within individual geographic regions. Thus, com-
mon ancestors were not inferred from the tree topology
directly, since tree clusters were based only on minimal
differences between the sequences compared (indepen-
dently of the pathways used in diversification) whereas
the ancestor determination applied was a complex pro-
cess, determining the most parsimonious pathway to
maximally relate the set of sequences under study while
minimizing the phyletic diversity. Importantly, the com-
mon ancestor approach accounts for uncertainty in the
underlying phylogeny by using a large number of plausi-
ble trees. In order to understand correctly the results,
we have considered that low AI and PS values represent
strong phylogeny-trait association and MC is positively
correlated with the strength of the phylogeny-trait asso-
ciation [59]. Thus, high AIs and PSs and low MCs show
sequences’ compartmentalization. To better understand
the clonal origin of collected sequences, Bayesian
MCMC approaches described by Lemey and coauthors
[35] and developed for phylogeographical applications
were applied. Specifically, according to Lemey and colla-
borators, the state of each sequence was represented by
its geographical origin and the analyses lead to infer
about the state of each internal node: this approach
allowed to follow the viral evolution through the space
of assigned states. We used BEAST package software
[60] to infer about the state of internal nodes within the
phylogeny of each animal. In this work, we assigned as
state the animal tissue from which each sequence was
obtained. Parameters were estimated using the Bayesian
method implemented in the BEAST software package
and the convergence of chains was assessed by calculat-
ing the Effective Sample Size (ESS) of the runs. All para-
meter estimates showed significant ESS (> 200).
Maximum Clade Credibility (MCC) phylogeny and
information about common ancestors’ state were
obtained using Tree Annotator.
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for possible amino acid positions that would provide a
conserved pattern within the SNC Env sequences rela-
tive to the PBMC or BAL Env sequences. The analysis
was calculated with the VESPA software [61] that deter-
mines the frequency of an amino acid at a specific posi-
tion and then determined whether there was a distinct
pattern for one set of sequences.
Nucleotide sequences accession number
The SRLV-env sequence data generated in this study were
deposited into GenBank database and are available under
accession numbers: BAL 166 (JF288187-JF288213), Cpx
166 (JF288214-JF288223), L 166 (JF288224-JF288235),
PBMC 166 (JF288236-JF288255), SC 166 (JF288256-
JF288276), Cpx 223 (JF288277-JF288289), L 223
(JF288290-JF288293), MG 223 (JF288294-JF288299),
PBMC 223 (JF288300-JF288304), SC 223 (JF288305-
JF288308), SC 292 (JF288309-JF288315), BAL 333
(JF28831-JF288329), Cpx 333 (JF288330-JF288345), L 333
(JF288346-JF288353), MG 333 (JF288354-JF288359),
PBMC 333 (JF288360-JF288376), SC 333 (JF288377-
JF288389), BAL 336 (JF288390-JF288403), L 336
(JF288404-JF288415), MG 336 (JF288416-JF288440), SC
336 (JF288441-JF288453), BAL 368 (JF288454-JF288467),
Cpx 368 (JF288468-JF288482), L 368 (JF288483-
JF288485), MG 368 (JF288486), SC 368 (JF288487-
JF288496), SC 697 (JF288497-JF288508), MG 698
(JF288509-JF288524), PBMC 698 (JF288525-JF288528), SC
698 (JF288529-JF288536).
Additional material
Additional file 1: Phylogenetic tree including 350 partial env
sequences from 8 animals. Taxa names include the animal number, the
tissue from which the sequence was obtained and the clone number.
Tissues are identified by a three-letter code as follows: broncho-alveolar
macrophages BAL, choroid plexus CPx, spinal cord SCO, peripheral blood
mononuclear cells PBM, mammary gland MGL, lung LUN. Animal clusters
are depicted in different colors. Sequences presenting stop codons
within the 698 animal clade are reported in gray. Posterior probability
supporting tree’s nodes are reported.
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